Arcinova hosts event to aid the pharmaceutical sector

Paul Quigley, Head of API Development and Bioanalytical Services at Arcinova, presented at the (NEPIC) Pharmaceutical Conference.
Paul Quigley, Head of API Development and Bioanalytical Services at Arcinova, presented at the (NEPIC) Pharmaceutical Conference.

Contract research and development organisation, Arcinova, has played a key role in further strengthening the region’s pharmaceutical sector.

The Alnwick-based company hosted this year’s North East of England Process Industry Cluster (NEPIC) Pharmaceutical Conference on Tuesday.

The NEPIC is a membership cluster organisation, covering a broad sweep of chemistry-focussed industries including pharmaceuticals, biotechnology, petrochemicals, polymers and materials, fine and speciality chemicals and renewables.

The conference brought together an expert panel of speakers and industry professionals who provided insights into a number of aspects of high potency processing, including categorisation, process development issues, manufacturers’ perspectives, equipment and engineering design issues.

The North East is home to more than 1,000 life science and healthcare companies that together employ 38,000 people, generate a combined turnover of £10.5billion and contribute 33 per cent of the UK’s pharmaceutical GDP.

The sector is growing and expecting to recruit additional jobs to its current manufacturing and research workforce this financial year (2017-2018).

Ian Shott, MD at Arcinova, said: “We are delighted to be working with NEPIC to help strengthen and promote the pharmaceutical sector in the North East and it gave us great pleasure to host this conference in Northumberland.

“At Arcinova, we are committed to helping the sector in the North East grow and prosper, so that it can provide even more high-value jobs and play an ever-increasing role in serving the global pharmaceutical and biotech sectors.”

Arcinova recently announced a collaboration with Cramlington-based Sterling Pharma Solutions. As a result, Arcinova now has access to Sterling Pharma Solutions’ scale up and pilot plant assets, complementing the company’s existing facilities in Alnwick.

Arcinova has also announced the award of a £1.5million Innovate UK grant for the development of new flexible modular manufacturing technologies, a project which will demonstrate the operating feasibility of world first innovative continuous production tools.

Spanning a three-year period, it will be undertaken in collaboration with the University of Nottingham.